SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
669 What is the difference of having the stock at 15/16 or at $ 1.00. Ask the markeAngelo-9/4/1999
668 Craig, the abstract says that a class of drugs, the NMDA antagonists, have greaDr. John M. de Castro-9/3/1999
667 Can you put that into English for us laymen? <g> Sort of reminds me of tCraig S. Owens-9/3/1999
666 Hi John, I once spent my free time in a Physical Therapy Clinical reading a teBRAVEHEART-9/3/1999
665 Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor aDr. John M. de Castro-9/3/1999
664 Jeffrey, I know what it is investing in biotech, I am more like a gambler then Angelo-9/1/1999
663 Hi Angelo, Might is a pivitol catch 22. Yes NTII has significant potential. BRAVEHEART-9/1/1999
662 Thanks for the information, I searched and I didn't find much on the companAngelo-8/31/1999
661 Angelo, All you have to do is some research on the company and memantine and yoDr. John M. de Castro-8/31/1999
660 >> Can any body give me a good reason for buying NTII without hyping. <dch-8/31/1999
659 Can any body give me a good reason for buying NTII without hyping. Angelo Angelo-8/31/1999
658 Excellent review of the rationale for use of memantine in AIDS-dementia complexDr. John M. de Castro-8/23/1999
657 AFTER the FACT, Hi John, The current MERZ trials for Memantine give the impreBRAVEHEART-8/19/1999
656 Memantine.Com reports I just scanned through the Merz site memantine.com It hDr. John M. de Castro-8/18/1999
655 Memantine is a safe & effective neuroprotectant in a neonatal stroke model.Dr. John M. de Castro-8/18/1999
654 Statistical significance is based upon three factors; the efect size (the 30% yDr. John M. de Castro-8/16/1999
653 Another Article...John this one is directed at you & Terry... See: MessagBRAVEHEART-8/16/1999
652 Hi Gang, I was just going over some past articles and one "spiked" sBRAVEHEART-8/16/1999
651 TECHNICALS: Typical low volume sell-off. This suggests there is little wrong BRAVEHEART-8/16/1999
650 TREATMENT vrs CURE Hi John, Am I alone in thinking that NTI's approach isBRAVEHEART-8/16/1999
649 Another Neuropathic Pain Competitor Bites the Dust NTII's memantine for neuDr. John M. de Castro-8/16/1999
648 Hi Gang, Yes investing takes much patience. NTII has gone from .50 to $1.5 inBRAVEHEART-8/6/1999
647 To all those who are bailing I don't blame you. The urge to sell when NTII Dr. John M. de Castro-8/5/1999
646 'Eeek: I Sold my last 5k of NTII at 1 17/32' did ya ?? I had made up Apache Indian-8/5/1999
645 (this is an off topic chit chat message intended for the handful of acquaintancMike McFarland-8/5/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News